Stroke Trial, Recruiting NCT07208019 Sponsor: Ruijie Ma Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07208019
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with vascular cognitive impairment according to the 2024 Chinese medical guidelines for this condition (both Western and Traditional Chinese Medicine diagnostic standards apply).
  • People whose scores on standard memory and thinking tests fall within a specific range — showing some cognitive difficulties, but not severe dementia (confirm with trial site for exact score requirements).
  • People aged between 35 and 80 years old.
  • People who are able to hold a basic conversation in Mandarin and have at least one consistent caregiver supporting them.
  • People who have signed a form agreeing to take part in the trial.

Who may not be able to join:

  • People who have serious long-term conditions affecting the heart, liver, kidneys, hormonal system, or blood, or who have severe heart or blood vessel disease.
  • People who have skin conditions such as open sores, herpes, or scarring that could make acupuncture and moxibustion (a heat-based Traditional Chinese Medicine treatment) unsuitable for them.
  • People who are unable to have repeated MRI scans — for example, due to severe claustrophobia or because they have had certain types of brain aneurysm treatment.
  • People who had cognitive impairment or another serious neurological or mental health condition before this illness began, and whose condition is not well managed.
  • People who have taken part in another clinical trial for a related condition within the past 3 months.
  • People who trial staff determine are not suitable for this study for other reasons.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ruijie Ma, The Third Affiliated hospital of Zhejiang Chinese Medical University

Phone: +86 13967988987

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ruijie Ma
Registry
ClinicalTrials.gov
Start date
5 October 2025
Est. completion
30 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Neuropsychological Test Battery(NTB); Montreal Cognitive Assessment; Mini-Mental State Examination

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov